课题基金 / 基金详情

CORE--CLINICAL

CORE--CLINICAL
核心--临床
批准号:
6659203
负责人:
AZRA RAZA
金额:
$31.28万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-01 至 2003-05-31

项目摘要

项目成果

AZRA RAZA的其他基金

相关文献

中文摘要
翻译
临床核心的功能是确保临床方面 大多数研究都是以高效和有效的方式进行的。这个 CORE将确保每一家参与机构都有 日期临床方案,患者在研究之前注册的日期 研究的启动,所有患者都有资格参加 他们被研究和治疗的研究。它的另一个功能是 核心是确保拟议的临床数据 及时获得研究结果并提供给生物统计核心 举止。该核心还将确保临床样本是 在适当的时间获得并被运送到核心 加工、分配和储存实验室。的成员 此核心将与适当的人员保持持续联系,地址为 合作机构确保所有的研究和 标本采集工作进展顺利。核心意志 对所有诊断和治疗也采用统一的标准 结果评估。
英文摘要
The function of the Clinical Core is to insure that the clinical aspects of the studies are conducted in an efficient and effective manner. The core will insure that each of the participating Institutions have up to date clinical protocols, that patients are registered onto studies prior to the initiation of the studies, and that all patients are eligible for the studies on which they are studied and treated. Another function of this Core is to insure that the clinical data necessary for the proposed studies is obtained and provided to the Biostatistical Core in a timely manner. The Core will also insure that clinical specimens are obtained at the appropriate time and transported to the Core Laboratory for processing, distribution, and storage. The members of this Core will be in constant contact with the appropriate individuals at the collaborating Institutions to insure that all of the studies and specimen collections are proceeding without difficulty. The Core will also apply uniform criteria for all diagnoses and for all treatment outcome evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prediction of Response to Revlimid
Prediction of Response to Revlimid
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY
  • 批准号:
    7720819
  • 项目类别:
  • 资助金额:
    $24.37万
  • 财政年份:
    2008
  • 负责人:
    AZRA RAZA
  • 依托单位:
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY
  • 批准号:
    7610427
  • 项目类别:
  • 资助金额:
    $17.16万
  • 财政年份:
    2007
  • 负责人:
    AZRA RAZA
  • 依托单位: